1800 202 8726
Liquid Biopsy & Newer Methods

Tumour Markers vs — Liquid Biopsy

Many labs in India use these two terms interchangeably. They are not the same test, they do not measure the same thing, and they answer different questions for your oncologist.

Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026

  • Different measurements — Tumour markers measure proteins. Liquid biopsy reads tumour DNA. One blood draw is not like the other.
  • Different questions — Markers tell you whether cancer cells are active. Liquid biopsy can tell you which mutations are driving them.
  • Neither diagnoses cancer — An elevated marker or a positive liquid biopsy result is never a diagnosis on its own. Tissue biopsy remains the standard.
  • Liquid biopsy is not a screen — Liquid biopsy is not yet validated as a routine population screening tool in India. Using it that way is not current evidence-based practice.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get an indicative cost estimate

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Report reviewed by a senior oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Tumour markers and liquid biopsy are not the same test. Tumour markers measure proteins that cancer cells release into blood. Liquid biopsy detects fragments of tumour DNA. Each gives different information, and neither replaces a tissue biopsy for diagnosing cancer in the first place.

How are tumour markers different from liquid biopsy?

Tumour MarkersLiquid Biopsy
What it measuresProteins, enzymes or hormones released by cancer cells or by the body in response to cancerFragments of tumour DNA (ctDNA) shed by the tumour into the bloodstream
What it tells youWhether tumour cells appear to be active, and broadly how muchWhich specific mutations are present in the tumour
Main clinical usesMonitoring response to treatment; watching for recurrence after treatment endsSelecting targeted therapy; detecting when resistance to a drug develops
Can it diagnose cancer?No — many non-cancerous conditions raise these levelsNo — cannot replace tissue biopsy for initial diagnosis
Widely available in India?Yes — most common panels available at standard laboratoriesSpecialist centres only; not uniformly available across India
Indicative cost (2026)Lower — many markers available at public-sector tariffsSubstantially higher — varies by the mutations being tested
Replaces tissue biopsy?NoNo

Why do labs sometimes advertise these as the same thing?

Both tests use a blood draw, which is where the confusion starts. Some laboratory marketing in India labels tumour marker panels as 'liquid biopsy' because the method of collection is the same. The laboratory work and the information returned are completely different.

A tumour marker panel runs your blood through a chemistry analyser and reports a protein level. A liquid biopsy sequences the DNA in your blood, can take days and specialist equipment to complete, and costs considerably more.

If a test was ordered for you and you are not sure which kind it was, ask: 'Was this a protein marker test or a DNA-sequencing test?' Your oncologist or the laboratory report should be able to answer that directly.

What will this actually cost you?

Costs depend on the regimen, the number of cycles and your scheme eligibility. Send your reports and we will give you an itemised, indicative estimate.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Know the cost before you commit

An itemised estimate, plus a check of which schemes you may qualify for.

Book Free Consultation Call 1800 202 8726

What do these terms actually mean?

Tumour marker
A protein, enzyme or hormone measurable in blood that rises in some cancers. Common examples include PSA for prostate cancer and CA-125 for ovarian cancer. Elevated levels are a reason to investigate further, not a diagnosis on their own. Many non-cancerous conditions raise the same markers.
Liquid biopsy
A blood test that looks for fragments of DNA shed by tumour cells into the bloodstream, called circulating tumour DNA or ctDNA. It can reveal the specific mutations driving a tumour, which guides choices between targeted therapies. It supplements tissue biopsy in some situations but does not replace it.
ctDNA (circulating tumour DNA)
Small amounts of DNA that tumour cells release into the blood as they divide or die. Liquid biopsy detects these fragments to identify mutations without a surgical or needle biopsy — useful when a tumour is hard to reach, or when monitoring for resistance after targeted treatment.
Tissue biopsy
A sample of tumour tissue obtained by needle, surgery or endoscopy and examined under a microscope. It remains the standard method for diagnosing cancer. No blood test currently replaces it for a first diagnosis.

Did you know?

PSA — the prostate tumour marker — has been measured in routine blood tests since the 1980s. Liquid biopsy using DNA sequencing became clinically available only in the last decade, and evidence for its use in different cancers continues to mature.

The two tests share a blood draw and very little else.

Source: ASCO and ESMO guidance on circulating biomarkers in oncology

Explore 62 more Biopsy Techniques and How They Compare topics

All Biopsy Techniques and How They Compare →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Are tumour markers and liquid biopsy the same test?

No. Both use a blood sample, but that is where the similarity ends. Tumour markers measure proteins that cancer cells or surrounding tissue release into the blood. Liquid biopsy sequences DNA fragments shed by the tumour. They answer different questions and the results are interpreted completely differently. Some Indian labs use the term 'liquid biopsy' for tumour marker panels, which is inaccurate — ask your oncologist or the laboratory to confirm which type of test was actually ordered.

Can liquid biopsy replace a tissue biopsy?

Not for an initial diagnosis. Tissue biopsy — a sample of tumour taken by needle or surgery — remains the standard method for diagnosing cancer. Liquid biopsy has a role in specific situations: when a tumour is hard to reach for repeat biopsy, when monitoring for resistance mutations after targeted therapy, or when tracking treatment response over time. ESMO and ASCO guidance is clear that liquid biopsy supplements tissue biopsy in these settings; it does not replace it for first diagnosis.

My tumour marker came back high. Does that mean the cancer is back?

A raised tumour marker is a signal to investigate, not a confirmed recurrence. Many non-cancerous conditions — infections, inflammation, benign cysts, and some medications — can raise the same markers. Your oncologist will look at the result alongside your history, your symptoms and usually a scan before drawing any conclusion. A single marker result, rising or falling, is always interpreted in context. Do not wait to share the result — call your oncology team so they can decide what comes next.

Is liquid biopsy testing available at CION?

Liquid biopsy testing can be coordinated through CION centres, usually by sending the sample to a specialist molecular diagnostics laboratory. Availability and the specific mutations that can be tested depend on your cancer type and the clinical question your oncologist is trying to answer. Because not every liquid biopsy panel is appropriate for every cancer, this is a conversation to have with your treating oncologist rather than ordering the test independently.

Which test should I be asking my oncologist about?

That depends on where you are in your treatment. If you are on treatment and your oncologist is monitoring response, a tumour marker relevant to your cancer type may be the appropriate test. If a targeted therapy has stopped working and your oncologist wants to know why, a liquid biopsy may help identify a resistance mutation. Neither test is universally better — each answers a different question at a different point in care. The right question to ask your oncologist is: what specific question are you trying to answer with this blood test?

A private lab is offering liquid biopsy for early cancer detection. Is that reliable?

Liquid biopsy for population-level cancer screening is not yet established as standard practice in India or internationally. Tests in this space are being studied in large clinical trials, and guidance from ASCO, ESMO and ICMR has not yet established them as routine screening tools. That does not mean the technology will not get there — it means the evidence is still maturing. If you have a family history or a specific concern about cancer risk, speak to an oncologist about which screening approach is appropriate for you, rather than ordering an unvalidated test independently.

Full index

Browse all 701 biopsy topics

Every page in this section, grouped by the part of the journey it belongs to. Pick a group to see what is in it.

What Is a Biopsy?

What Is a Biopsy? Everything You Need to Know →

Types of Biopsy Compared

Which Biopsy Will You Have? Techniques Compared →

Preparing for a Biopsy

What to Expect on the Day of Your Biopsy →

Recovery and Aftercare

After a Biopsy: Recovery, Aftercare and Warning Signs →

Biopsy by Body Part

Biopsy by Body Part: What to Expect at Each Site →

Understanding Your Report

How to Read a Biopsy Report: Terms Explained →

IHC and Molecular Markers

IHC and Molecular Markers on a Biopsy: What They Mean →

Grading and Scoring Systems

Cytology & Prostate Scoring Systems Explained →

How Accurate Is a Biopsy?

How Accurate Is a Biopsy? Errors and Second Opinions →

If Your Result Is Benign

Your Biopsy Is Benign: What It Means and What Comes Next →

Call now Book free consultation